ADBiotech Co

ADBiotech Co Equity Turnover

The Equity Turnover of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 0.84. In the previous year, Equity Turnover was 2.30 — a change of -63.44% (lower).

Equity Turnover

0.84

YoY

-63.44%

Last updated:

Equity Turnover of ADBiotech Co is 2025 0.84 . Equity Turnover of ADBiotech Co was 2024 2.30 . It decreases by -63.44% lower compared to the previous year.

The ADBiotech Co Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2018
1.64 KRW
Jan 1, 2019
1.38 KRW
Jan 1, 2020
1.05 KRW
Jan 1, 2021
2.32 KRW
Jan 1, 2022
0.66 KRW
Jan 1, 2023
0.78 KRW
Jan 1, 2024
2.30 KRW
Jan 1, 2025
0.84 KRW
The ADBiotech Co Equity Turnover history
YEAREquity TurnoverYoY
0.84-63.44%
2.30+194.45%
0.78+19.04%
0.66-71.68%
2.32+120.38%
1.05-23.54%
1.38-16.23%
1.64+9.75%
1.50-4.02%
1.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Equity Turnover of ADBiotech Co is 0.84 in 2025.

Equity Turnover of ADBiotech Co changed from 2.30 to 0.84, representing a -63.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's ADBiotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ADBiotech Co

All Key Metrics — ADBiotech Co